Skip to main content
Top
Published in: BMC Nephrology 1/2004

Open Access 01-12-2004 | Research article

Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting

Authors: Giorgio Coen, Eleonora Moscaritolo, Carlo Catalano, Raffaella Lavini, Italo Nofroni, Giuseppe Ronga, Daniela Sardella, Alvaro Zaccaria, Rosario Cianci

Published in: BMC Nephrology | Issue 1/2004

Login to get access

Abstract

Background

Renal artery stenosis (RAS) is a known cause of hypertension and ischemic nephropathy. Stenting of the artery is a valid approach, in spite of cases of unexpected adverse evolution of renal function.

Methods

In this study, 27 patients with unilateral RAS were subjected to stenting and followed for a period of one year, while 19 patients were observed while on medical treatment only. The group of 27 patients, 67.33 ± 6.8 years of age, creatinine of 2.15 ± 0.9 mg/dl, following stenting, were followed at intervals with biochemical tests, renal scintigraphy and doppler ultrasonography. The control group (70.0 ± 6.1 years, creatinine 1.99 ± 0.7 mg/dl) was also followed for one year.

Result

One year after stenting mean creatinine clearance (Ccr) increased from 36.07 ± 17.2 to 40.4 ± 21.6 ml/min (NS). Arterial BP, decreased after 1,3,6, and 12 months (p < 0.05). The number of antihypertensive drugs also decreased (p < 0.05). A significant increase in proteinuria was also observed. In the control group both Ccr, BP and proteinuria did not show significant changes. Based on renal scintigraphy and Ccr at subsequent times, it was possibile to evaluate the timecourse of renal function in both kidneys of the stented patients. In the stented kidneys Ccr increased significantly. On the controlateral kidney a decrease of renal function (p < 0.05) was observed. Resistance index appeared to be a risk factor of the functional outcome.

Conclusions

Stenting of RAS due to atherosclerosis is followed by stabilization or improvement of Ccr, mainly at the stented kidney, while contralateral renal function showed a decrease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meyrier A, Hill GS, Simon P: Ischemic renal disease: new insights into old entities. Kidney Int. 1998, 54: 2-13. 10.1046/j.1523-1755.1998.06802.x.CrossRefPubMed Meyrier A, Hill GS, Simon P: Ischemic renal disease: new insights into old entities. Kidney Int. 1998, 54: 2-13. 10.1046/j.1523-1755.1998.06802.x.CrossRefPubMed
2.
go back to reference Scoble JE: Atherosclerotic nephropathy. Kidney Int. 1999, 56 (supl.71): S106-109. 10.1046/j.1523-1755.1999.07126.x.CrossRef Scoble JE: Atherosclerotic nephropathy. Kidney Int. 1999, 56 (supl.71): S106-109. 10.1046/j.1523-1755.1999.07126.x.CrossRef
3.
go back to reference Harding MB, Smith LR, Himmelstein SI, Harrison K, Philips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashmore TM: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992, 2: 1608-1616.PubMed Harding MB, Smith LR, Himmelstein SI, Harrison K, Philips HR, Schwab SJ, Hermiller JB, Davidson CJ, Bashmore TM: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992, 2: 1608-1616.PubMed
4.
go back to reference Coen G, Calabria S, Lai S, Moscaritolo E, Nofroni I, Ronga G, Rossi M, Ventroni G, Sardella D, Ferrannini M, Zaccaria A, Cianci R: Atherosclerotic ischemic renal disease: Diagnosis and prevalence in an hypertensive and/or uremic elderly population. BMC Nehrology. 2003, 4: 2-10.1186/1471-2369-4-2.CrossRef Coen G, Calabria S, Lai S, Moscaritolo E, Nofroni I, Ronga G, Rossi M, Ventroni G, Sardella D, Ferrannini M, Zaccaria A, Cianci R: Atherosclerotic ischemic renal disease: Diagnosis and prevalence in an hypertensive and/or uremic elderly population. BMC Nehrology. 2003, 4: 2-10.1186/1471-2369-4-2.CrossRef
5.
go back to reference Plouin PF, Rossignol P, Bobrie G: Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate?. J Am Soc Nephrol. 2001, 12: 2190-2196.PubMed Plouin PF, Rossignol P, Bobrie G: Atherosclerotic renal artery stenosis: to treat conservatively, to dilate, to stent, or to operate?. J Am Soc Nephrol. 2001, 12: 2190-2196.PubMed
6.
go back to reference Dorros G, Jaff M, Mathiak L, He T: Multicenter Palmaz stent renal artery stenosis revascularization registry report: four years follow-up of 1,058 successful patients. Catheter Cardiovasc Interv. 2002, 55: 182-188. 10.1002/ccd.3050.CrossRefPubMed Dorros G, Jaff M, Mathiak L, He T: Multicenter Palmaz stent renal artery stenosis revascularization registry report: four years follow-up of 1,058 successful patients. Catheter Cardiovasc Interv. 2002, 55: 182-188. 10.1002/ccd.3050.CrossRefPubMed
7.
go back to reference Muray S, Martin M, Amoedo ML, Garcia C, Jornet AR, Vera M, Oliveras A, Gomez X, Craver L, Real MI, Garcia L, Botey A, Montanya X, Fernandez E: Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002, 39: 60-66.CrossRefPubMed Muray S, Martin M, Amoedo ML, Garcia C, Jornet AR, Vera M, Oliveras A, Gomez X, Craver L, Real MI, Garcia L, Botey A, Montanya X, Fernandez E: Rapid decline in renal function reflects reversibility and predicts the outcome after angioplasty in renal artery stenosis. Am J Kidney Dis. 2002, 39: 60-66.CrossRefPubMed
8.
go back to reference Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ: Primary renal artery stenting: characteristics and outcome after 363 procedures. Am Heart J. 2001, 142: 314-323. 10.1067/mhj.2001.116958.CrossRefPubMed Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ: Primary renal artery stenting: characteristics and outcome after 363 procedures. Am Heart J. 2001, 142: 314-323. 10.1067/mhj.2001.116958.CrossRefPubMed
9.
go back to reference Airoldi F, Palatresi S, Marana I, Bencini C, Benti C, Benti R, Lovaria A, Alberti C, Nador B, Nicolini A, Longari V, Gerundivi P, Morganti A: Angioplasty of atherosclerotic and fibronuscular renal artery stenosis: time corse and predicting factors of the effects on renal function. Am J Hypertens. 2000, 13: 1210-1217. 10.1016/S0895-7061(00)01206-1.CrossRefPubMed Airoldi F, Palatresi S, Marana I, Bencini C, Benti C, Benti R, Lovaria A, Alberti C, Nador B, Nicolini A, Longari V, Gerundivi P, Morganti A: Angioplasty of atherosclerotic and fibronuscular renal artery stenosis: time corse and predicting factors of the effects on renal function. Am J Hypertens. 2000, 13: 1210-1217. 10.1016/S0895-7061(00)01206-1.CrossRefPubMed
10.
go back to reference Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998, 98: 642-647.CrossRefPubMed Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, He T: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998, 98: 642-647.CrossRefPubMed
11.
go back to reference Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000, 102: 1671-1677.CrossRefPubMed Watson PS, Hadjipetrou P, Cox SV, Piemonte TC, Eisenhauer AC: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation. 2000, 102: 1671-1677.CrossRefPubMed
12.
go back to reference Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H, et al: Use of Doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N Engl J Med. 2001, 344: 410-417. 10.1056/NEJM200102083440603.CrossRefPubMed Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, Galanski M, Koch KM, Haller H, et al: Use of Doppler ultrasonography to predict the outcome of therapy for renal artery stenosis. N Engl J Med. 2001, 344: 410-417. 10.1056/NEJM200102083440603.CrossRefPubMed
13.
go back to reference La Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF: Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol. 2001, 12: 1235-1241.PubMed La Batide-Alanore A, Azizi M, Froissart M, Raynaud A, Plouin PF: Split renal function outcome after renal angioplasty in patients with unilateral renal artery stenosis. J Am Soc Nephrol. 2001, 12: 1235-1241.PubMed
14.
go back to reference Leertouwer TC, Derkx FHM, Pattynamia PMT, Deinum J, Van Dijk LC, Schalekamp MADH: Functional effects of renal artery stent placement on treated and controlateral kidneys. Kidney Int. 2002, 62: 574-579. 10.1046/j.1523-1755.2002.00456.x.CrossRefPubMed Leertouwer TC, Derkx FHM, Pattynamia PMT, Deinum J, Van Dijk LC, Schalekamp MADH: Functional effects of renal artery stent placement on treated and controlateral kidneys. Kidney Int. 2002, 62: 574-579. 10.1046/j.1523-1755.2002.00456.x.CrossRefPubMed
15.
go back to reference Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41.CrossRefPubMed Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41.CrossRefPubMed
16.
go back to reference Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali WP: Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol. 2001, 12: 1475-1481.PubMed Beutler JJ, Van Ampting JM, Van De Ven PJ, Koomans HA, Beek FJ, Woittiez AJ, Mali WP: Long-term effects of arterial stenting on kidney function for patients with ostial atherosclerotic renal artery stenosis and renal insufficiency. J Am Soc Nephrol. 2001, 12: 1475-1481.PubMed
17.
go back to reference Perkovi V, Thomson KR, Becker GJ: Factors affecting outcome after percutaneous renal artery stent insertion. J Nephrol. 2002, 15: 649-654.PubMed Perkovi V, Thomson KR, Becker GJ: Factors affecting outcome after percutaneous renal artery stent insertion. J Nephrol. 2002, 15: 649-654.PubMed
18.
go back to reference Rocha-Sing KJ, Ahudia RK, Sung CH, Rutherford J: Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002, 57: 135-141. 10.1002/ccd.10296.CrossRef Rocha-Sing KJ, Ahudia RK, Sung CH, Rutherford J: Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Catheter Cardiovasc Interv. 2002, 57: 135-141. 10.1002/ccd.10296.CrossRef
19.
go back to reference Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999, 92: 159-167. 10.1093/qjmed/92.3.159.CrossRefPubMed Isles CG, Robertson S, Hill D: Management of renovascular disease: a review of renal artery stenting in ten studies. QJM. 1999, 92: 159-167. 10.1093/qjmed/92.3.159.CrossRefPubMed
20.
go back to reference Makanjuola AD, Scoble JE: Ischaemic nephropathy-is the diagnosis excluded by heavy proteinuria?. Nephrol Dial Transplant. 1999, 14: 2795-2797. 10.1093/ndt/14.12.2795.CrossRefPubMed Makanjuola AD, Scoble JE: Ischaemic nephropathy-is the diagnosis excluded by heavy proteinuria?. Nephrol Dial Transplant. 1999, 14: 2795-2797. 10.1093/ndt/14.12.2795.CrossRefPubMed
21.
go back to reference Thadhani R, Pascual M, Nickeleit V, Tokoff-Rubin N, Colvin R: Preliminary description of focal segmental glomeruloscelrosis in patients with renovascular disease. Lancet. 1996, 347: 231-233. 10.1016/S0140-6736(96)90406-7.CrossRefPubMed Thadhani R, Pascual M, Nickeleit V, Tokoff-Rubin N, Colvin R: Preliminary description of focal segmental glomeruloscelrosis in patients with renovascular disease. Lancet. 1996, 347: 231-233. 10.1016/S0140-6736(96)90406-7.CrossRefPubMed
Metadata
Title
Atherosclerotic renal artery stenosis: one year outcome of total and separate kidney function following stenting
Authors
Giorgio Coen
Eleonora Moscaritolo
Carlo Catalano
Raffaella Lavini
Italo Nofroni
Giuseppe Ronga
Daniela Sardella
Alvaro Zaccaria
Rosario Cianci
Publication date
01-12-2004
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2004
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-5-15

Other articles of this Issue 1/2004

BMC Nephrology 1/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.